1-6 of 6
renal cyst
Close
Sort by
Journal Articles

Phase II, Multicenter Trial, Exploring "Chemo-Sparing" Strategy Associating Obinutuzumab+Ibrutinib Followed By a MRD Driven Strategy, in Previously Untreated Symptomatic Medically Fit Chronic Lymphocytic Leukemia Patients (CLL): Preliminary Results of the Induction Phase of the Icll-07 Filo Study

Anne-Sophie Michallet, MD PhD, Marie-Sarah Dilhuydy, MD, Fabien Subtil, Valérie Rouille, Beatrice Mahe, MD, Kamel Laribi, Bruno Villemagne, Gilles Andre Salles, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Christelle Portois, Brigitte Pegourie, MD, Veronique Leblond, Cecile Tomowiak, MD, Sophie de Guibert, Frederique Orsini, Anne Banos, MD, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, MD PhD, Caroline Dartigeas, Margot Truchan, Thérèse Aurran, MD, Florence Cymbalista, MD, Stéphane Leprêtre, MD, Vincent Levy, MD PhD, Florence Nguyen Khac, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Remi Letestu, Pierre Feugier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 497.
https://doi.org/10.1182/blood.V130.Suppl_1.497.497
Published: 2017
Journal Articles

Prevalence of Extramedullary Hematopoiesis, Vertebral, Hepatic and Splenic Hemangioma and Renal Cyst Among Thalassaemic Patients: A Retrospective Study from the Myocardial Iron in Thalassemia (MIOT) Network

Alessia Pepe, Antonella Meloni, Alessandra Briatico Vangosa, Fabrizia Terrazzino, Maria Giovanna Neri, Domenico Maddaloni, Gaetano Roccamo, Sabrina Armari, Aurelio Maggio, MD, Cristina Salvatori, Vincenzo Positano, Paolo Ricchi
Journal: Blood
Blood (2015) 126 (23): 2154.
https://doi.org/10.1182/blood.V126.23.2154.2154
Published: 2015
Journal Articles

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

David B. Sykes, MD, PhD, Wilfried A. Schroyens, MD, PhD, Casey L. O'Connell, MD, Donald I. Feinstein, MD, Hasan Bazari, MD, Douglas M. Dahl, MD, Robert B. Colvin, MD, Bernard P. Paelinck, MD, PhD, Raul N. Uppot, MD, Bart Op de Beeck, MD, William Boswell, MD, Noopur S. Raje, MD, Nancy Lee Harris, MD, Eyal C. Attar, MD
Journal: Blood
Blood (2011) 118 (21): 1037.
https://doi.org/10.1182/blood.V118.21.1037.1037
Published: 2011
Journal Articles

High False Positive Rate with the Use of CT and FDG-PET in Post-Remission Surveillance for Hodgkin Lymphoma.

Dan Zuckerman, MD, Ann Lacasce, MD, Eric Jacobsen, MD, Tak Takvorian, MD, Ephraim Hochberg, MD
Journal: Blood
Blood (2007) 110 (11): 2327.
https://doi.org/10.1182/blood.V110.11.2327.2327
Published: 2007
Journal Articles

Hematocrit-Driven Referrals for Measurement of RBC Mass. Is the Natural History of Polycythemia Vera Changing?.

Thein H. Oo, MD, Sumit Gaur, MD, Janet Tierney, BS, Alan Ashare, MD, Robert Weinstein, MD
Journal: Blood
Blood (2005) 106 (11): 4960.
https://doi.org/10.1182/blood.V106.11.4960.4960
Published: 2005
Journal Articles

Feasibility of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy for Non-Hodgkin’s Lymphoma in a Patient with Chronic Renal Failure.

Stewart M. Spies, MD, Leo I. Gordon, MD, A. Michael Zimmer, PHD, Peter Cutrera, CNMT
Journal: Blood
Blood (2004) 104 (11): 4642.
https://doi.org/10.1182/blood.V104.11.4642.4642
Published: 2004